Demant has announced the launch of Oticon’s new premium rechargeable hearing aid, Oticon Reveal , and it’s twice the announcement the hearing market was expecting. And it comes bundled with an H1 financial report showing 7% organic growth in the first half of 2026, ahead of expectations , for the Denmark-based manufacturer....
Continue reading at Audiology Worldnews
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable clinical change — this is a product launch announcement; audiologists should await independent performance data before adjusting fitting or recommendation practices.
Oticon Reveal's dual-AI architecture signals an industry-wide push toward multi-model AI processing in premium hearing aids, potentially raising patient expectations and competitive pricing pressure across the market.
- 01Demant launched Oticon Reveal, a premium rechargeable hearing aid with a dual AI processing system.
- 02The launch exceeded internal and market expectations, described as 'twice' the anticipated impact.
- 03Demant reported 7% organic growth in H1 2026, beating market forecasts.
- 04Reveal is positioned in the premium tier and is rechargeable.
- 05No independent clinical trial data on Reveal's performance has been published alongside the launch.
Oticon Reveal features a dual AI system for sound processing.
press releaseunclearDemant achieved 7% organic growth in H1 2026, exceeding market expectations.
press releasesupportedThe Reveal launch is described as twice the launch anyone expected.
press releasepromotional